Mortality Benefit of Recombinant Human Interleukin-1...

  • Main
  • 2017 / 10
  • Mortality Benefit of Recombinant Human Interleukin-1...
Critical Care Medicine 2017 / 10

Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration

Meyer, Nuala J., Reilly, John P., Anderson, Brian J., Palakshappa, Jessica A., Jones, Tiffanie K., Dunn, Thomas G., Shashaty, Michael G. S., Feng, Rui, Christie, Jason D., Opal, Steven M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Critical Care Medicine
DOI:
10.1097/ccm.0000000000002749
Date:
October, 2017
File:
PDF, 215 KB
english, 2017
Conversion to is in progress
Conversion to is failed